Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening. Martin RM, Dixon P, Turner E, Keeney E, et al. BJU Int 2022;129:269-270.

Read + Share

Amedeo Smart

Independent Medical Education